Talphera (TLPH) Projected to Post Quarterly Earnings on Wednesday

Talphera (NASDAQ:TLPHGet Free Report) is projected to announce its earnings results before the market opens on Wednesday, March 5th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter.

Talphera Price Performance

Shares of NASDAQ TLPH opened at $0.54 on Tuesday. The stock’s fifty day moving average price is $0.61 and its two-hundred day moving average price is $0.76. Talphera has a one year low of $0.50 and a one year high of $1.35. The firm has a market cap of $9.20 million, a price-to-earnings ratio of -0.78 and a beta of 0.29.

Wall Street Analysts Forecast Growth

TLPH has been the topic of several analyst reports. Maxim Group raised Talphera to a “strong-buy” rating in a report on Friday, November 8th. Rodman & Renshaw initiated coverage on Talphera in a report on Tuesday, January 28th. They set a “buy” rating and a $4.00 target price on the stock. RODMAN&RENSHAW raised Talphera to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, HC Wainwright reissued a “buy” rating and set a $6.00 target price on shares of Talphera in a report on Tuesday, January 21st.

Read Our Latest Report on TLPH

About Talphera

(Get Free Report)

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.

Featured Stories

Earnings History for Talphera (NASDAQ:TLPH)

Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.